AUS
NZ
UK
CA
USA
IND
Healthcare
Zimmer Biomet’s Performance Reflects Resilience
October 03, 2024 12:27 PM PDT| By Team Kalkine MediaHighlights,Zimmer Biomet’s price-to-earnings ratio is higher than many peers, reflecting expectations of continued earnings growth and market outperformance.,The company has achieved strong earnings growth recently, which justifies the higher valuati...
Amgen's Institutional Influence and Strategic Direction
October 03, 2024 11:22 AM PDT| By Team Kalkine MediaHighlights:,Institutional investors have the majority of shares in Amgen, indicating significant influence over the company’s decisions and strategy.,Despite heavy institutional ownership, no single shareholder dominates Amgen, ensuring a diverse spr...
Elevance Health Sees Strong Institutional Backing as Investors Increase Stakes
October 03, 2024 09:49 AM PDT| By Team Kalkine MediaHeadlines,Major investors are increasing their involvement in Elevance Health, indicating confidence in the company's prospects.,Multiple investment firms have recently established new stakes in Elevance Health, reflecting growing interest in the fir...
Validation of Wound Measurement Technology Accomplished by Spectral AI Through Proof-of-Concept.
October 03, 2024 06:45 AM PDT| By Team Kalkine MediaHighlights:,Spectral AI completes a proof-of-concept module for its wound measurement technology, integrated into the DeepView System.,The technology provides fast and accurate total body surface area calculations for burn wounds, enhancing treatment...
Lumos Diagnostics Secures Funding from the US for FebriDx® Test and Regulatory Initiatives
October 03, 2024 05:27 AM PDT| By Team Kalkine MediaHighlights,Lumos Diagnostics Holdings Ltd secures nearly $3 million in non-dilutive funding from BARDA for its FebriDx® rapid diagnostic test.,The funding will support a clinical study for a CLIA waiver and FDA regulatory submission, aiming to expand...
Oncocyte Corporation (Nasdaq: OCX) Expands Market Presence with GraftAssure™ Agreements
October 03, 2024 04:36 AM PDT| By Team Kalkine MediaKey Highlights:,Oncocyte partners with top transplant hospitals in the U.S. and Germany for GraftAssure™.,The Company aims for FDA clearance for clinical use of its dd-cfDNA kitted test.,Strong demand for GraftAssure exceeds expectations, bolstered b...
Perspective Therapeutics Earnings Forecast: Analyst Insights
October 03, 2024 04:32 AM PDT| By Team Kalkine MediaHeadlines,Wedbush updates earnings projections for Perspective Therapeutics,Company shows slight earnings improvement despite losses,Multiple analysts offer positive outlook on stock performance,Wedbush,(NYSE:WFC),has recently provided insights into...
CVS Health Explores Splitting Retail and Insurance Divisions
October 01, 2024 11:02 AM PDT| By Team Kalkine MediaHighlights,CVS Health Corp's strategic review could lead to possible separation of its retail and insurance divisions.,Integration between Aetna and CVS has been a focus since the 2018 acquisition, improving healthcare services.,A potential breakup r...
Haleon’s Rating Reconfirmed After Changes in Pfizer's Stake
October 01, 2024 04:35 AM PDT| By Team Kalkine MediaHighlights,Pfizer Inc. has reduced its stake in Haleon PLC, leading to a significant share repurchase.,UBS has reaffirmed its positive rating on Haleon following this development.,Haleon plans to cancel half of the repurchased shares as part of its s...
Corporate Split Readiness Noted at CVS
October 01, 2024 03:33 AM PDT| By Team Kalkine MediaHighlights,Potential Split,: CVS Health Corp is considering separating its retail and insurance divisions, potentially creating two publicly traded entities.,Investor Pressure,: The move comes in response to investor concerns following a lowered 2024...
Pfizer (NYSE:PFE) announces sale of shares in Haleon to raise £2.7bn
September 30, 2024 08:16 PM PDT| By Team Kalkine MediaPfizer Inc. (NYSE:PFE) is set to raise approximately £2.7 billion ($3.6 billion) through the sale of shares in Haleon Plc, as the pharmaceutical giant continues to reduce its stake in the UK-based consumer health company. This move underscores Pfizer...
RxSight's Ownership Structure Reveals Key Shareholders
September 30, 2024 03:14 PM PDT| By Team Kalkine MediaHighlights,RxSight is primarily controlled by institutions, giving them significant influence over the company's decisions and direction.,Despite a recent market cap decline, the company's performance over the past year may ease some concerns for the...
Perrigo Receives Positive Rating from Canaccord Genuity Group
September 30, 2024 10:20 AM PDT| By Team Kalkine MediaHeadlines,Several analysts have updated their perspectives on Perrigo, reflecting varied outlooks.,Canaccord Genuity Group recently assigned a favorable rating, while others provided a more cautious outlook.,Perrigo's recent stock performance has bee...
These Pharma Giants Gain Momentum in Obesity and Diabetes Treatments
September 30, 2024 09:28 AM PDT| By Team Kalkine MediaHighlights,The GLP-1 market for obesity and diabetes treatments is gaining momentum, with Novo Nordisk and Eli Lilly leading the space.,Citi experts highlight increased prescriptions for obesity drugs like Wegovy and diabetes treatments such as Ozemp...
Citi Highlights Strong Demand Growth for Wegovy and Ozempic
September 30, 2024 08:35 AM PDT| By Team Kalkine MediaHighlights,Significant Prescription Increases,: Citi reports a 244% rise in prescriptions for obesity drugs and an 18% increase for diabetes medications.,Strong Sales Forecasts,: Estimated sales for Novo Nordisk and Eli Lilly in diabetes are projecte...
NanoViricides Prepares for Phase II Trials of Antiviral NV-387
September 30, 2024 05:52 AM PDT| By Team Kalkine MediaHighlights:,NV-387, a broad-spectrum antiviral, progresses to Phase II clinical trials targeting multiple viral infections.,Demonstrated superior efficacy in preclinical studies compared to existing antivirals, including Tamiflu and Xofluza.,Ongoing...
Genflow Biosciences Reports Significant Progress in Interim Results
September 30, 2024 05:17 AM PDT| By Team Kalkine MediaHighlights,Advancements in Longevity Treatments,: Genflow Biosciences has made notable progress in developing therapies for age-related diseases, specifically Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Werner Syndrome.,Regulatory Eng...
Chill Brands Group Shifts Focus to Viable Nicotine-Free Vapour Products
September 30, 2024 04:57 AM PDT| By Team Kalkine MediaHighlights,Chill Brands Group PLC is advancing plans for an audit review and new product launches, following secured banking provisions.,The reinstatement of CEO Callum Sommerton has provided clarity as the company navigates past challenges, includin...
Why is Viking Therapeutics (NASDAQ:VKTX) gaining limelight recently?
September 30, 2024 12:33 AM PDT| By Team Kalkine MediaViking Therapeutics (NASDAQ:VKTX), a clinical-stage biopharmaceutical company, is making significant strides in the development of a weight-loss drug that could shake up the highly competitive obesity medication market. While the company has multiple...
Stryker Corporation to Issue Dividend Payment
September 29, 2024 09:09 AM PDT| By Team Kalkine MediaHeadlines,Stryker Corporation is set to distribute a dividend to its shareholders at the end of October.,The dividend payment aligns with the company's strategy of providing consistent returns.,Despite the payout, the yield remains relatively modest...
